On Friday, President Trump signed a new executive order which lowered the cost of drugs by tying them to the price consumers pay outside of the United States. Dr. Michelle McMurry-Heath, President and CEO of the Biotechnology Innovation Organization (BIO), joins The Final Round panel to discuss the impact that this could have on the pharmaceutical industry. …read more
Source:: Yahoo Finance
